StockData

Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3037% below fair value
$1.15+0.03 (+2.68%)

Close on Nov 18, 2026Market cap $9.63MP/E –Yield –

Femasys net income

Net income is the profit left for shareholders after every expense, interest and tax.

Femasys's net income for the twelve months ending Jun 30, 2026 was -$11.77M. For fiscal 2025 it was -$18.63M. The highest annual figure on record is -$6.91M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.63M–
FY2024Dec 31, 2024-$18.82M–
FY2023Dec 31, 2023-$14.25M–
FY2022Dec 31, 2022-$11.39M–
FY2021Dec 31, 2021-$7.54M–
FY2020Dec 31, 2020-$6.91M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.47M–
Q1 FY2026Mar 31, 2026$846.10K–
Q4 FY2025Dec 31, 2025-$3.95M–
Q3 FY2025Sep 30, 2025-$4.19M–
Q2 FY2025Jun 30, 2025-$4.59M–
Q1 FY2025Mar 31, 2025-$5.90M–
Q4 FY2024Dec 31, 2024-$5.12M–
Q3 FY2024Sep 30, 2024-$5.41M–
Q2 FY2024Jun 30, 2024-$4.68M–
Q1 FY2024Mar 31, 2024-$3.60M–
Q4 FY2023Dec 31, 2023-$4.41M–
Q3 FY2023Sep 30, 2023-$4.00M–
Q2 FY2023Jun 30, 2023-$2.89M–
Q1 FY2023Mar 31, 2023-$2.95M–
Q4 FY2022Dec 31, 2022-$2.89M–
Q3 FY2022Sep 30, 2022-$2.98M–
Q2 FY2022Jun 30, 2022-$2.63M–
Q1 FY2022Mar 31, 2022-$2.88M–
Q4 FY2021Dec 31, 2021-$2.36M–
Q3 FY2021Sep 30, 2021-$2.26M–
Q2 FY2021Jun 30, 2021-$1.08M–
Q1 FY2021Mar 31, 2021-$1.83M–
Q4 FY2020Dec 31, 2020-$1.66M–
Q3 FY2020Sep 30, 2020-$1.57M–
Q2 FY2020Jun 30, 2020-$1.49M–

More Femasys figures

See a number that looks wrong?